These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 60793)

  • 21. Thrombophilia and complex acquired deficiencies of antithrombin, protein C, and protein S.
    Humphries JE
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):8-16; discussion 17-8. PubMed ID: 8821205
    [No Abstract]   [Full Text] [Related]  

  • 22. Activity of antithrombin III and effect of heparin on coagulation in shock.
    Blauhut B; Necek S; Kramar H; Vinazzer H; Bergmann H
    Thromb Res; 1980 Sep; 19(6):775-82. PubMed ID: 7466746
    [No Abstract]   [Full Text] [Related]  

  • 23. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
    Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
    Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombin III profiles in malignancy, relationship primary tumors and metastatic sites.
    Honegger H; Anderson N; Hewitt LA; Tullis JL
    Thromb Haemost; 1981 Aug; 46(2):500-3. PubMed ID: 7302888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of an amidolytic heparin cofactor assay method.
    Odegård OR
    Thromb Res; 1975 Aug; 7(2):351-60. PubMed ID: 51519
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemostatic function in cancer patients.
    Kies MS; Posch JJ; Giolma JP; Rubin RN
    Cancer; 1980 Aug; 46(4):831-7. PubMed ID: 7397648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advances in the laboratory diagnosis of disorders of hemostasis].
    Sawicka B
    Pol Tyg Lek; 1985 Jul; 40(28):806-9. PubMed ID: 3903694
    [No Abstract]   [Full Text] [Related]  

  • 28. [Physiopathology of consumption coagulopathies].
    Cuocolo R; Ortolani O; Conti A
    Minerva Anestesiol; 1980 Jul; 46(7):827-42. PubMed ID: 7017463
    [No Abstract]   [Full Text] [Related]  

  • 29. Antithrombin deficiency in special clinical syndromes--Part II: panel discussion #2.
    Sacher R
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):67-71. PubMed ID: 8821213
    [No Abstract]   [Full Text] [Related]  

  • 30. Fluorometric assay of antithrombin III. Diagnostic value in 112 patients with abnormal hemostasis.
    Napoli VM; Krzyzaniak R; Vroon DH; Newton JL
    Am J Clin Pathol; 1985 Aug; 84(2):173-9. PubMed ID: 4025221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of heparin elimination from plasma in the assessment of coagulogram and antithrombin III activity].
    Momot AP; Sokolov EA; Tseĭmakh IIa
    Klin Lab Diagn; 1995; (5):31-4. PubMed ID: 7582773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
    Sobczyk J; Swietliński J; Podleśny-Owsińska T
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
    [No Abstract]   [Full Text] [Related]  

  • 33. Surgical treatment of abdominal aortic aneurysm complicated with chronic disseminated intravascular coagulopathy.
    Goto H; Kimoto A; Kawaguchi H; Tadakuma K; Kaneko Y; Uemura K; Miyauchi Y; Nakagawa Y
    J Cardiovasc Surg (Torino); 1985; 26(3):280-2. PubMed ID: 3997969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased proteolysis of antithrombin III Vicenza during disseminated intravascular coagulation in acute leukemia.
    Castaman G; Ruggeri M; Rodeghiero F
    Thromb Res; 1989 Sep; 55(5):661-4. PubMed ID: 2814948
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of heparin therapy in Dispholidus typus envenomation: an experimental study.
    Atkinson PM; Rebello M; Gaillard MC; Bradlow BA
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):355-63. PubMed ID: 6798704
    [No Abstract]   [Full Text] [Related]  

  • 36. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
    Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
    Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pro and con: Consumption coagulopathy--heparin treatment? Arguments against heparin treatment].
    Straub PW
    Internist (Berl); 1980 Jul; 21(7):385-6. PubMed ID: 7007275
    [No Abstract]   [Full Text] [Related]  

  • 38. Antithrombin assay - the use of human or bovine thrombin and the observation of a "second" heparin cofactor.
    Friberger P; Egberg N; Holmer E; Hellgren M; Blombäck M
    Thromb Res; 1982 Mar; 25(5):433-6. PubMed ID: 7071813
    [No Abstract]   [Full Text] [Related]  

  • 39. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
    Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H
    Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of the disseminated intravascular coagulation syndrome in ischemic heart disease patients with congestive circulatory failure].
    Panchenko EP
    Kardiologiia; 1981 Aug; 21(8):50-5. PubMed ID: 7289383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.